“有偿献血”应该得到鼓励 | 经济学人

文章预览

📢  文末扫码进裙，免费领取双语精读版 People should be paid for blood plasma  Shortages are hampering the production of essential medicines. The Economist  blood plasma  29 August, 2024 | 658 words | ★★ ★ ★ ☆   The trade in human blood might seem gruesome. In fact, it is essential. Plasma, the main component of blood, is a crucial ingredient for a range of medicines, from haemophilia treatments to rabies vaccines and tetanus jabs. And these days there is not enough of it to go around. Health services around the world have faced shortages of plasma-derived medicines since at least 2018. The covid-19 pandemic made matters worse. With donors in lockdown, supply was constrained, prompting authorities in France and Italy to instruct doctors how best to ration treatments. Outside America, Australia and Canada, plasma-based medicines are underused. The situation is especially dire in poor countries, which use a fraction of the amount needed to treat even just ………………………………